Hollow Brook Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$423K Sell
1,202
-110
-8% -$39.2K 0.11% 65
2025
Q4
$429K Sell
1,312
-1,548
-54% -$491K 0.11% 68
2025
Q3
$807K Buy
2,860
+1,548
+118% +$449K 0.19% 60
2025
Q2
$366K Hold
1,312
0.11% 70
2025
Q1
$409K Hold
1,312
0.12% 65
2024
Q4
$342K Hold
1,312
0.11% 70
2024
Q3
$423K Buy
1,312
+132
+11% +$43.2K 0.13% 69
2024
Q2
$369K Hold
1,180
0.13% 65
2024
Q1
$335K Hold
1,180
0.12% 67
2023
Q4
$340K Hold
1,180
0.14% 67
2023
Q3
$317K Hold
1,180
0.13% 68
2023
Q2
$262K Sell
1,180
-102
-8% -$23.7K 0.11% 76
2023
Q1
$310K Hold
1,282
0.15% 65
2022
Q4
$337K Buy
1,282
+282
+28% +$75.6K 0.16% 65
2022
Q3
$225K Sell
1,000
-5
-0.5% -$1.21K 0.13% 67
2022
Q2
$245K Hold
1,005
0.13% 64
2022
Q1
$243K Hold
1,005
0.11% 66
2021
Q4
$226K Buy
+1,005
New +$212K 0.12% 72

Other funds holding AMGN

Hollow Brook Wealth Management's AMGN Position: Q1 2026 in Review

Hollow Brook Wealth Management reduced its Amgen (AMGN) stake by 8.4% in Q1 2026, selling an estimated $39.2K and leaving 1,202 shares worth $423K. The position accounts for 0.11% of the portfolio, ranked #65.

Hollow Brook Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $807K in Q3 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hollow Brook Wealth Management held 1,202 shares of Amgen worth $423K as of Q1 2026.
  • Hollow Brook Wealth Management sold 110 Amgen shares in Q1 2026, an estimated $39.2K.
  • Amgen made up 0.11% of Hollow Brook Wealth Management's portfolio in Q1 2026, its #65 holding.
  • Hollow Brook Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Hollow Brook Wealth Management's Amgen position peaked at $807K in Q3 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hollow Brook Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.